In care homes, antipsychotic medication is commonly prescribed to control so called 'behavioural and psychological symptoms of dementia' such as agitation, aggression, or restlessness. However, it is questionable whether antipsychotic medication is effective and safe. Adverse effects, such as sedation, falls, and cardiovascular symptoms, are frequent. Therefore, antipsychotic medication should be avoided if possible. This review investigates whether psychosocial interventions aimed at reducing antipsychotic medication in care homes are effective. By psychosocial interventions, we mean programmes that consist of different non-pharmacological components including talking to the staff, residents, or both. We identified four randomised controlled trials for inclusion in the review. All studies examined, among other components, education targeted at nursing staff in care homes. The methodological quality of three studies was limited, one study showed high quality. In all studies the interventions led to a reduction of antipsychotic medication use, but the overall magnitude of the effect remains unclear.
Psychosocial interventions for reducing antipsychotic medication in care home residents
Published Online:
December 12, 2012
More like this
- Withdrawal of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia
- Atypical antipsychotics benefit people with dementia but the risks of adverse events may outweigh the benefits, particularly with long term treatment
- Insufficient evidence for the efficacy and safety of antidepressants for depression in dementia
- No evidence to support the use of thioridazine for dementia
- No evidence of efficacy of valproate preparations for treatment of agitation in people with dementia
